BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12665316)

  • 21. [Effect of nylestriol and levonorgestrel on the expression of estrogen receptor subtypes in human osteosarcoma MG-63 cell lines].
    Yang K; Liao E; Zhou H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1248-53. PubMed ID: 21200092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats.
    Nuttall ME; Bradbeer JN; Stroup GB; Nadeau DP; Hoffman SJ; Zhao H; Rehm S; Gowen M
    Endocrinology; 1998 Dec; 139(12):5224-34. PubMed ID: 9832463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
    Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
    Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of bone structure and quality of ovariectomized rats by microcrack].
    Dai RC; Liao EY; Yang C
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):591-6. PubMed ID: 15804068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats.
    Kippo K; Hannuniemi R; Virtamo T; Laurén L; Ikävalko H; Kovanen V; Osterman T; Sellman R
    Bone; 1995 Dec; 17(6):533-42. PubMed ID: 8835307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
    Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
    Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    Sato M; Bryant HU; Iversen P; Helterbrand J; Smietana F; Bemis K; Higgs R; Turner CH; Owan I; Takano Y; Burr DB
    J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term effects of calcium and exercise on bone mineral density in ovariectomized rats.
    Gala J; Díaz-Curiel M; de la Piedra C; Calero J
    Br J Nutr; 2001 Oct; 86(4):521-7. PubMed ID: 11591240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Simvastatin and Combination of Simvastatin and Nylestriol on Bone Metabolism in Ovariectomized Rats.
    Li XF; Lin CB; Xie FR; Liang WG; Ji J; Yang Y
    Am J Ther; 2016; 23(6):e1630-e1636. PubMed ID: 26171988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis.
    Hoffmann DB; Komrakova M; Pflug S; von Oertzen M; Saul D; Weiser L; Walde TA; Wassmann M; Schilling AF; Lehmann W; Sehmisch S
    J Bone Miner Metab; 2019 Mar; 37(2):243-255. PubMed ID: 29785666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bone metabolism in postmenopausal women and after estrogen treatment].
    Song SJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):79-81, 122. PubMed ID: 8344086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized rats.
    Li X; Song QS; Wang JY; Leng HJ; Chen ZQ; Liu ZJ; Dang GT; Song CL
    J Bone Miner Metab; 2011 Jul; 29(4):396-403. PubMed ID: 21063740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic effect of dietary boron supplement on retinoic acid-induced osteoporosis in rats].
    Xu P; Hu WB; Guo X; Zhang YG; Li YF; Yao JF; Cai QK
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1785-8. PubMed ID: 17259120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
    Kidder LS; Schmidt IU; Evans GL; Turner RT
    Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
    Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD
    Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Sato M; Zeng GQ; Rowley E; Turner CH
    Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA; Hegazy S; El-Desoky K
    Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat.
    Ke HZ; Qi H; Crawford DT; Chidsey-Frink KL; Simmons HA; Thompson DD
    Endocrinology; 2000 Apr; 141(4):1338-44. PubMed ID: 10746637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.